Multidirectional pattern of hair growth with carflizomib use for multiple myeloma.

Shahaf Tuler Jaspreet KaurSuzette DelawareConstantin A Dasanu

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

A score of 5 on the Naranjo nomogram makes the causality relationship between carfilzomib use and the multidirectional hair growth probable. The mechanism by which carfilzomib causes this hair change remains to be elucidated.

Keyphrases

multiple myeloma
lymph node metastasis
adverse drug
electronic health record
drug induced